Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, heart wellness capsules, menstrual discomfort relief, liver detox tablets, liver-dispersing and stomach regulating pills, fever- removing and detoxification pills, kidney invigoration pills, and huoxiang zheng qi pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and for symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.
Metrics to compare | 1643 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1643PeersSector | |
---|---|---|---|---|
P/E Ratio | 45.7x | −18.3x | −0.5x | |
PEG Ratio | −0.57 | 0.01 | 0.00 | |
Price/Book | 0.9x | 4.0x | 2.6x | |
Price / LTM Sales | 2.1x | 7.6x | 3.3x | |
Upside (Analyst Target) | - | −9.8% | 43.4% | |
Fair Value Upside | Unlock | −14.1% | 7.1% | Unlock |